VOLUNTARY ANNOUNCEMENT AMENDMENT TO THE ADVANCE PURCHASE AGREEMENTAdvance Purchase Agreement • April 21st, 2021
Contract Type FiledApril 21st, 2021This announcement is made by the board (the “Board”) of directors (the “Directors”) of Clover Biopharmaceuticals, Ltd. (the “Company”) on a voluntary basis to inform the shareholders of the Company and potential investors on the latest business development of the Group.